Aytu BioScience, Inc. (AYTU): Price and Financial Metrics
AYTU Price/Volume Stats
Current price | $3.04 | 52-week high | $3.50 |
Prev. close | $3.08 | 52-week low | $1.38 |
Day low | $3.01 | Volume | 15,205 |
Day high | $3.12 | Avg. volume | 19,862 |
50-day MA | $2.90 | Dividend yield | N/A |
200-day MA | $2.40 | Market Cap | 16.93M |
AYTU Stock Price Chart Interactive Chart >
AYTU POWR Grades
- AYTU scores best on the Value dimension, with a Value rank ahead of 90.36% of US stocks.
- The strongest trend for AYTU is in Value, which has been heading up over the past 26 weeks.
- AYTU ranks lowest in Stability; there it ranks in the 11th percentile.
AYTU Stock Summary
- With a market capitalization of $16,034,371, AYTU BIOPHARMA INC has a greater market value than just 7.55% of US stocks.
- With a price/sales ratio of 0.16, AYTU BIOPHARMA INC has a higher such ratio than merely 4.01% of stocks in our set.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AYTU comes in at 46.36% -- higher than that of 96.05% of stocks in our set.
- Stocks that are quantitatively similar to AYTU, based on their financial statements, market capitalization, and price volatility, are TOMZ, MITQ, ANGI, TREE, and GVP.
- AYTU's SEC filings can be seen here. And to visit AYTU BIOPHARMA INC's official web site, go to aytubio.com.
AYTU Valuation Summary
- In comparison to the median Healthcare stock, AYTU's EV/EBIT ratio is 103.42% lower, now standing at -0.5.
- Over the past 106 months, AYTU's price/sales ratio has gone down 1.8.
Below are key valuation metrics over time for AYTU.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
AYTU | 2023-12-29 | 0.2 | 0.5 | -0.6 | -0.5 |
AYTU | 2023-12-28 | 0.2 | 0.5 | -0.7 | -0.5 |
AYTU | 2023-12-27 | 0.2 | 0.5 | -0.7 | -0.5 |
AYTU | 2023-12-26 | 0.2 | 0.5 | -0.7 | -0.5 |
AYTU | 2023-12-22 | 0.2 | 0.5 | -0.7 | -0.5 |
AYTU | 2023-12-21 | 0.2 | 0.5 | -0.7 | -0.5 |
AYTU's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- AYTU has a Quality Grade of D, ranking ahead of 15.62% of graded US stocks.
- AYTU's asset turnover comes in at 0.311 -- ranking 147th of 682 Pharmaceutical Products stocks.
- SYRS, ONVO, and GTHX are the stocks whose asset turnover ratios are most correlated with AYTU.
The table below shows AYTU's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.311 | 0.445 | -6.155 |
2021-03-31 | 0.311 | 0.508 | -2.810 |
2020-12-31 | 0.334 | 0.683 | -2.327 |
2020-09-30 | 0.301 | 0.723 | -2.482 |
2020-06-30 | 0.265 | 0.727 | -23.603 |
2020-03-31 | 0.194 | 0.749 | 8.971 |
AYTU Price Target
For more insight on analysts targets of AYTU, see our AYTU price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $17.50 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Aytu BioScience, Inc. (AYTU) Company Bio
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Latest AYTU News From Around the Web
Below are the latest news stories about AYTU BIOPHARMA INC that investors may wish to consider to help them evaluate AYTU as an investment opportunity.
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register NowMIAMI, Dec. 06, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 65th Emerging Growth Conference on December 6th and 7th, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting |
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023Webcasted presentation to take place at 1:10pm ETDENVER, CO / ACCESSWIRE / November 30, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that ... |
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call TranscriptAytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript November 14, 2023 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.00148, expectations were $-0.04. Robert Blum: Good afternoon, everyone, and thank you for joining us for Aytu BioPharma’s Fiscal 2024 First Quarter Financial Results Conference Call for the period ended September 30, 2023. Joining […] |
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial ResultsQ1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in Q1 2024Q1 2024 ADHD net revenue up 31% compared to Q1 2023$20.0 million cash balance at September 30, 2023Company to host conference ... |
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive YearRanked 118th Fastest Growing Company in North AmericaRanked 23rd Fastest Growing Life Sciences CompanyDENVER, CO / ACCESSWIRE / November 8, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing ... |
AYTU Price Returns
1-mo | 7.04% |
3-mo | 7.04% |
6-mo | 12.59% |
1-year | 42.06% |
3-year | -97.97% |
5-year | -99.09% |
YTD | 7.04% |
2023 | -24.87% |
2022 | -86.00% |
2021 | -77.42% |
2020 | -38.51% |
2019 | 23.10% |
Continue Researching AYTU
Here are a few links from around the web to help you further your research on Aytu Bioscience Inc's stock as an investment opportunity:Aytu Bioscience Inc (AYTU) Stock Price | Nasdaq
Aytu Bioscience Inc (AYTU) Stock Quote, History and News - Yahoo Finance
Aytu Bioscience Inc (AYTU) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...